You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Developing Novel Antibiotics Against Yersinia pestis
SBC: NOVOBIOTIC PHARMACEUTICALS, LLC Topic: N/ADESCRIPTION (provided by applicant): The overall goal of this project is to develop broad-spectrum antibiotics against Yersinia pestis and other important human pathogens. The potential use of engineered, multi-drug-resistant strains as agents of bioterrorism necessitates the development of new anti-Y. pestis therapies. This is a challenging goal, since the last novel class of broad-spectrum antib ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Modeling the Impact of Technology Transition on Ship Operational Capabilities
SBC: BEACON INTERACTIVE SYSTEMS LLC Topic: N05053During Phase I, we experimented with several transition approaches and ran into three hurdles: 1) No matter how good the method for transitioning technology, if the development process has not been well-managed, there will be no technology to transition; 2) Transition does not happen without an incredible amount of expertise and data; 3) Good technology does not matter if no one is aware of its e ...
SBIR Phase II 2006 Department of DefenseNavy -
Immunoassay for diagnosis of Babesia infection
SBC: IMMUNETICS, INC. Topic: RDESCRIPTION provided by applicant In this Phase II project development and clinical validation of an ELISA test for in vitro diagnosis of Babesia microti infection will be completed Babesiosis is an emerging tick borne parasitic disease which may cause severe to fatal illness in immunocompromised or otherwise weakened patients and may be carried in the blood subclinically in up to of the ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Babesia antigen detection assay for blood screening
SBC: IMMUNETICS, INC. Topic: NHLBIDESCRIPTION provided by applicant Human babesiosis is a malaria like illness caused by infection of red blood cells by the protozoan parasite Babesia microti or related species primarily transmitted to humans through the bite of infected deer ticks Babesiosis can also be transmitted by blood transfusion and is currently acknowledged as the foremost unaddressed infectious risk to the US blood ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Discovery of B. pseudomallei therapeutics for Biodefense
SBC: MICROBIOTIX, INC. Topic: N/ADESCRIPTION (provided by applicant): Burkholderia pseudomallei is a bioterrorist threat. With the best current therapies, lethality is typically as high as 40%. The overall goal of this proposal is the development of new drugs against this organism. In Phase I, the high sequence similarity between 8. pseudomallei and its less virulent relative Pseudomonas aeruginosa was exploited to build innovati ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Automated Assistance with Metadata Generation (A2MG) Tools for PBA/IPB
SBC: CHILIAD PUBLISHING, INC. Topic: AF05098Chiliad's Phase II effort will implement and test enhancements and extensions of automated metadata generation capabilities designed in Phase I, and the tight integration of those capabilities with other software systems and applications. Some of the results of Chiliad’s SBIR funded efforts have already been deployed in operational production systems across the FBI, within new releases of the Bu ...
SBIR Phase II 2006 Department of DefenseAir Force -
Vector Identification and Gene Delivery Approach in Pigs
SBC: GWATHMEY, INC. Topic: N/ADESCRIPTION (provided by applicant): Heart failure (HF) represents an enormous clinical problem demanding effective therapeutic approaches. Despite advances in traditional approaches to its treatment, including pharmacological management, myocardial revascularization, mechanical assist devices, and transplantation, heart failure remains a leading cause of death worldwide. Therefore, a novel therap ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF SBIR TOPIC DIRECT TO PHASE II CLOSURE DEVICES FOR TRANSCAVAL ACCESS TO THE ABDOMINAL AORTA
SBC: TRANSMURAL SYSTEMS LLC Topic: NHLBINot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Antibiotics for Recalcitrant Infection
SBC: ARIETIS CORPORATION Topic: RDESCRIPTION provided by applicant The goal of the project is to develop a therapeutic capable of sterilizing recalcitrant chronic infections such as deep seated abscess osteomyelitis endocarditis and biofilms of indwelling devices Many of these infections are essentially untreatable and lead to substantial morbidity and mortality In many cases recalcitrance of an infection is not caused b ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
GhostSwimmer: Tactically Relevant, Biomimetically Inspired, Silent, Highly Efficient and Maneuverable Autonomous Fish Robot
SBC: BOSTON ENGINEERING CORPORATION Topic: N08T030Boston Engineerings proposed project significantly increases the Navys capabilities by providing a technology that performs superbly in tactically critical littoral and VSW applications currently unaddressed. We propose to advance the existing technology readiness level (TRL) by combining our GhostSwimmer AUV with actuation, sensing, payload, and processing technology as applicable. Our proposed p ...
SBIR Phase II 2015 Department of DefenseNavy